Diabetic-Friendly Drug-Eluting Stent System to Debut in India
Published date : 02 October 2012
Article date : 02 October 2012
Massdevice reports that Medtronic's Resolute Integrity stent is to make its market debut in India, following FDA clearance, in February.
They say that the device is the first of its kind approved for use in patients with diabetes in addition to coronary artery disease (CAD). With India hosting the 2nd largest population of diabetics in the world, the launch may be an important one for patients in the country as well as for the manufacturer's ongoing commitment to expanding the company's reach in emerging markets.
According to the Medtronic, CAD patients with diabetes represent a difficult-to-treat population, as they often have smaller and more complex arteries, longer lesions and a higher rate of treatment failures. Apparently, because of complications arising from the co-morbidity, many patients are treated with open heart surgery, a more invasive option that requires extended hospital care and recovery time.
Although percutaneous interventions are often used for diabetic patients with CAD, no drug-eluting stent had previously been approved specifically for that population.
Source: Massdevice, 28 September 2012
Read the full article here.